Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

American Journal of Cardiology

Volumn 109, Issue 5, 2012, Pages 624-628

  Shimada, Yuichi J ^a   Nakra, Navin C ^a   Fox, John T ^a   Kanei, Yumiko ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ARTICLE; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; INTRACORONARY INFUSION; META ANALYSIS; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS ASPIRATION; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; CORONARY VESSELS; ELECTROCARDIOGRAPHY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84857624987     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.10.016     Document Type: Article

References (25)

1. E.C. Keeley, J.A. Boura, C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20 (Pubitemid 36050955)
2. F. Zijlstra, J.C. Hoorntje, M.J. de Boer, S. Reiffers, K. Miedema, J.P. Ottervanger, A.W. van 't Hof, H. Suryapranata Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction N Engl J Med 341 1999 1413 1419 (Pubitemid 29513456)
3. The EPIC Investigators Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty N Engl J Med 330 1994 956 961
4. The EPIC Investigators Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months Lancet 343 1994 881 886
5. The EPILOG Investigators Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization N Engl J Med 336 1997 1689 1696
6. E.J. Topol, D.B. Mark, A.M. Lincoff, E. Cohen, J. Burton, N. Kleiman, D. Talley, S. Sapp, J. Booth, C.F. Cabot, K.M. Anderson, R.M. Califf EPISTENT Investigators Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial Lancet 354 1999 2019 2024
7. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study Lancet 349 1997 1429 1435
8. G. Ndrepepa, A. Kastrati, J. Mehilli, F.J. Neumann, J. ten Berg, O. Bruskina, F. Dotzer, M. Seyfarth, J. Pache, J. Dirschinger, P.B. Berger, A. Schmig One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial Eur Heart J 29 2008 455 461 (Pubitemid 351264175)
9. EPISTENT Investigators Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade Lancet 352 1998 87 92
10. G. De Luca, H. Suryapranata, G.W. Stone, D. Antoniucci, J.E. Tcheng, F.J. Neumann, F. Van de Werf, E.M. Antman, E.J. Topol Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
11. G. Montalescot, D. Antoniucci, A. Kastrati, F.J. Neumann, M. Borentain, A. Migliorini, C. Boutron, J.P. Collet, E. Vicaut Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up Eur Heart J 28 2007 443 449 (Pubitemid 47343560)
12. E. Romagnoli, F. Burzotta, C. Trani, G.G. Biondi-Zoccai, F. Giannico, F. Crea Rationale for intracoronary administration of abciximab J Thromb Thrombolysis 23 2007 57 63
13. J. Whrle, O.C. Grebe, T. Nusser, E. Al-Khayer, S. Schaible, M. Kochs, V. Hombach, M. Hher Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty Circulation 107 2003 1840 1843 (Pubitemid 36444121)
14. A.K. Kakkar, A. Moustapha, H.G. Hanley, M. Weiss, G. Caldito, P. Misra, P.C. Reddy, N. Tandon Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting Catheter Cardiovasc Interv 61 2004 31 34 (Pubitemid 38036787)
15. F. Bellandi, M. Maioli, M. Gallopin, A. Toso, R.P. Dabizzi Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention Catheter Cardiovasc Interv 62 2004 186 192 (Pubitemid 38788695)
16. J.G. Galache Osuna, J. Snchez-Rubio, I. Calvo, J.A. Diarte, A. Lukic, L.J. Placer Does intracoronary abciximab improve the outcome of percutaneous coronary interventions? A randomized controlled trial Rev Esp Cardiol 59 2006 567 574 (Pubitemid 44203201)
17. H. Thiele, K. Schindler, J. Friedenberger, I. Eitel, G. Frnau, E. Grebe, S. Erbs, A. Linke, S. Mbius-Winkler, D. Kivelitz, G. Schuler Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial Circulation 118 2008 49 57
18. O.F. Bertrand, J. Rods-Cabau, E. Larose, C.M. Nguyen, J.P. Dry, G. Proulx, L. Roy, P. Poirier, O. Costerousse, R. De Larochellire Effects of intracoronary compared to intravenous abciximab administration in patients undergoing transradial percutaneous coronary intervention: a sub-analysis of the EASY trial Int J Cardiol 136 2009 165 170
19. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, P. Avanzas, F. Bosa-Ojeda, S. Samimi-Fard, F. Marrero-Rodriguez, J.C. Kaski Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary interventioneffects on soluble CD40 ligand concentrations Atherosclerosis 206 2009 523 527
20. A. Iversen, U. Abildgaard, A. Galloe, P.R. Hansen, S. Galatius, J.K. Madsen, T. Engstroem, S. Pedersen, K.S. Jensen, J.S. Jensen Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial J Interv Cardiol 24 2011 105 111
21. P.R. Hansen, A. Iversen, J. Abdulla Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis J Invasive Cardiol 2 2010 278 282
22. Y.L. Gu, M.A. Kampinga, W.G. Wieringa, M.L. Fokkema, M.W. Nijsten, H.L. Hillege, A.F. van den Heuvel, E.S. Tan, G. Pundziute, R. van der Werf, S. Hoseyni Guyomi, I.C. van der Horst, F. Zijlstra, B.J. de Smet Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the Comparison of Intracoronary Versus Intravenous Abciximab Administration During Emergency Reperfusion o ST-Segment Elevation Myocardial Infarction (CICERO) trial Circulation 122 2010 2709 2717
23. O.F. Bertrand, J. Rods-Cabau, E. Larose, S. Rinfret, V. Gaudreault, G. Proulx, G. Barbeau, J.P. Dry, O. Gleeton, C. Manh-Nguyen, B. Nol, L. Roy, O. Costerousse, R. De Larochellire Early Discharge After Transradial Stenting of Coronary Arteries in Acute Myocardial Infarction (EASY-MI) Study Investigators Intracoronary compared to intravenous abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study Am J Cardiol 105 2010 1520 1527
24. S. Schulz, K.A. Birkmeier, G. Ndrepepa, W. Moshage, F. Dotzer, K. Huber, J. Dirschinger, M. Seyfarth, A. Schmig, A. Kastrati, J. Mehilli One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial Clin Res Cardiol 99 2010 795 802
25. H. Thiele, J. Whrle, P. Neuhaus, O. Brosteanu, P. Sick, R. Prondzinsky, R. Birkemeyer, M. Wiemer, S. Kerber, H. Schuehlen, K. Kleinertz, C. Axthelm, R. Zimmermann, H. Rittger, R.C. Braun-Dullaeus, B. Lauer, W. Burckhardt, M. Ferrari, M.W. Bergmann, R. Hambrecht, G. Schuler Abciximab Intracoronary Versus Intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) Investigators Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary Versus Intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial Am Heart J 159 2010 547 554